NCT04913662

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (estimated)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a phase I trial investigating the safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) using paclitaxel combined with intravenous FOLFOX therapy for gastric cancer patients with peritoneal metastasis.

Conditions

• Stomach Neoplasm
• Peritoneal Metastases

Interventions

Type	Name	Description
PROCEDURE	Pressurized Intraperitoneal Aerosol Chemotherapy	Aerosolization of chemotherapic agent for intraperitoneal chemotherapy

Timeline

• Start date: 2021-04-26
• Primary completion: 2022-04-26
• Completion: 2022-06-30
• First posted: 2021-06-04
• Last updated: 2021-06-04

Locations

1 site across 1 country: South Korea